抑制剂简介
抑制剂是一类能够降低或阻止生物体内的酶活性、受体的活性或是细胞内特定反应过程的小分子化合物。它们在有机化学、化学化工和生物医药领域中有着广泛的应用,尤其是在药物研发方面。
分类与作用机制
应用领域
总结
抑制剂的研究和发展对于理解生命过程至关重要,并在药物开发、基础科学研究等多个领域发挥着重要作用。随着技术的进步,新的抑制剂不断被发现和开发出来,为医学治疗提供了更多的可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | ANTROQUINONOL | 1010081-09-0 | C24H38O4 |
|
—— | (2S,3R)-N-(4-(2,6-dimethoxyphenyl)-5-(5-methylpyridin-3-yl)-4H-1,2,4-triazol-3-yl)-3-(5-methylpyrimidin-2-yl)butane-2-sulfonamide | 2049980-18-7 | C25H29N7O4S |
|
—— | BRL 15572 hydrochloride | 193611-72-2 | C25H28Cl2N2O |
|
—— | Ifenprodil hemitartrate | 23210-58-4 | C46H60N2O10 |
|
—— | (1R,2S,5S)-3-((S)-2-tert-butoxycarbonylamino-3,3-dimethylbutyryl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid | 394735-37-6 | C19H32N2O5 |
|
—— | (-)-N-[4-(2,2-dimethylpropionyl)-5-(2-ethylaminoethanesulfonylaminomethyl)-5-phenyl-4,5-dihydro-1,3,4-thiadiazol-2-yl]-2,2-dimethylpropanamide | 546111-97-1 | C23H37N5O4S2 |
|
—— | 2-[[(3-chloro-4-morpholino-pyridin-2-yl)methyl]sulfinyl]-5-methoxy-(1H)-benzimidazole | 103949-62-8 | C18H19ClN4O3S |
|
—— | N-((S)-1-(((S)-1-(benzo[d]thiazol-2-yl)-1-oxo-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1H-indole-2-carboxamide | 1471484-62-4 | C30H33N5O5S |
|
—— | glycyl-L-arginyl-glycyl-L-aspartyl-L-seryl-L-proline | 91037-75-1 | C22H37N9O10 |
|
—— | 2-[3,5-bis(trifluoromethyl)phenyl]-N-{4-(4-fluoro-2-methylphenyl)-6-[(7S,9aS)-7-(hydroxylmethyl)hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl]-3-pyridinyl}-N,2-dimethylpropanamide | 929046-33-3 | C33H35F7N4O3 |
|
—— | (6S,9aS)-N-benzyl-8-((6-(3-(4-ethylpiperazin-1-yl)azetidin-1-yl)pyridin-2-yl)methyl)-6-((2-fluoro-4-hydroxyphenyl)methyl)-4,7-dioxo-2-(prop-2-en-1-yl)-octahydro-1H-pyrazino[2,1-c][1,2,4]triazine-1-carboxamide | 1799824-08-0 | C39H48FN9O4 |
|
—— | OTS514 | 1338540-63-8 | C21H20N2O2S |
|
—— | PF-9366 | 72882-78-1 | C20H19ClN4 |
|
—— | 1-(4-pyridinyl)-3-(2-quinolinyl)-2-propen-1-one | 4382-63-2 | C17H12N2O |
|
—— | 1-(3-((3-((1H-pyrrol-2-yl)methylene)-2-oxoindolin-6-yl)amino)-4-methylphenyl)-3-(2-fluoro-5-(trifluoromethyl)phenyl)urea | 1033769-28-6 | C28H21F4N5O2 |
|
—— | trans-1-(4-chloro-3-trifluoromethylphenyl)-3-[4-(5-trifluoromethylpyridin-2-yloxy)cyclohexyl]urea | 1394011-91-6 | C20H18ClF6N3O2 |
|
—— | [3-(1-Benzyl-3-carbamoylmethyl-2-ethyl-1H-indol-5-yloxy)-propyl]-phosphonic acid | 164083-84-5 | C22H27N2O5P |
|
—— | PF-04928473 | 908112-43-6 | C23H27F3N4O3 |
|
—— | WEHI-345 (analog) | 1354825-62-9 | C23H25N7O |
|
—— | 5-bromo-N-(2,5-bis(trifluoromethyl)phenyl)-2-hydroxybenzamide | 439144-66-8 | C15H8BrF6NO2 |
|
—— | (S)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile | 1887014-12-1 | C18H15ClN4O2 |
|
—— | (R)-3-(2-(trans-4-(2-aminoethylamino)cyclohexyl)acetamido)-2-hydroxy-3,4-dihydro-2H-benzo[e][1,2]oxaborinine-8-carboxylic acid | 1613267-49-4 | C19H28BN3O5 |
|
—— | 7-benzyl-4,7-diazaspiro[2.5]octane-5,8-dione | 1222106-43-5 | C13H14N2O2 |
|
—— | furimazine | 1374040-24-0 | C24H19N3O2 |
|
—— | 2-(4-trifluoromethylphenyl)-3,5,7,8-tetrahydrothiopyrano[4,3-d]pyrimidin-4-one | 284028-89-3 | C14H11F3N2OS |
|
—— | N-(3,5-dimethylphenyl)-2-[[5-(4-ethylphenyl)-2H-1,2,4-triazol-3-yl]sulfanyl]acetamide | 1001478-90-5 | C20H22N4OS |
|
—— | AZD1390 | 2089288-03-7 | C27H32FN5O2 |
|
—— | N-({2-[4-(difluoromethoxy)-3-isopropoxyphenyl]oxazol-4-yl}methyl)-2-ethoxybenzamide | 937782-05-3 | C23H24F2N2O5 |
|
—— | 2-((1-((3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9<sup>,</sup>-xanthen]-5-yl)amino)-1-thioxo-6,9,12,15,18-pentaoxa-2-azahenicosan-21-yl)amino)-4-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indazol-1-yl)benzamide | 1562024-11-6 | C52H60N6O12S |
|
—— | (1H-indol-3-yl)(3-noradamantyl)methanone | 1097119-35-1 | C19H21NO |
|
—— | methyl 4-(6-(4-(3-(4-(hydroxymethyl)phenyl)ureido)phenyl)-4-morpholino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate | 1062172-60-4 | C30H34N8O5 |
|
—— | 3-(3,5-Dibromo-4-hydroxy-benzylidene)-5-iodo-1,3-dihydro-indol-2-one | 220904-83-6 | C15H8Br2INO2 |
|
—— | ML130 | 799264-47-4 | C14H13N3O2S |
|
—— | 5-(2,4-dichlorobenzylidene)thiazolidine-2,4-dione | 51244-45-2 | C10H5Cl2NO2S |
|
—— | 2'-cyclohexylamino-6-piperazin-1-yl[2,4']bipyridinyl-4-carboxylic acid amide | 1201673-28-0 | C21H28N6O |
|
—— | 4-(2-(2-ethoxyphenyl)hydrazono)-3-methyl-1-(4-phenylthiazol-2-yl)-1H-pyrazol-5(4H)-one | 331244-89-4 | C21H19N5O2S |
|
—— | R-Azasetron besylate | 2025360-91-0 | C23H26ClN3O6S |
|
—— | Motesanib diphosphate | 857876-30-3 | C22H29N5O9P2 |
|
—— | fagaronine | 52259-64-0 | C21H20NO4*Cl |
|
—— | 3-(1-(4-chlorophenyl)cyclopropyl)-8-cyclopropyl-[1,2,4]triazolo[4,3-a]pyridine | 1610952-07-2 | C18H16ClN3 |
|
—— | Cyclosporine A | 59865-13-3 | C62H111N11O12 |
|
—— | (3S,6R,9R,12R,15R,18S,24S,30S,33R)-30-ethyl-33-[(E,1S)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone | 59865-13-3 | C62H111N11O12 |
|
—— | [(13S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] 3-cyclopentylpropanoate | 313-06-4 | C26H36O3 |
|
—— | NVP-BSK805 | 1092499-93-8 | C27H28F2N6O |
|
—— | methyl (4aR,6aS,6bR,8aS,12aR,14bR)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,3,4,5,6,7,8,8a,14a,14b-decahydropicene-4a-carboxylate | 218600-53-4 | C32H43NO4 |
|
—— | (1R,9S,12S,13S,14S,17R,18Z,21S,23S,24R,25S,27R)-12-[(E)-1-[(1R,3R,4S)-4-chloro-3-methoxycyclohexyl]prop-1-en-2-yl]-17-ethyl-1,14-dihydroxy-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone | 137071-32-0 | C43H68ClNO11 |
|
—— | 4-(Phenylmethyl)-1-piperazineacetic Acid 2-[[2-Hydroxy-3-(2-propen-1-yl)phenyl] | 315183-21-2 | C23H28N4O2 |
|
—— | K252a | 97161-97-2 | C27H21N3O5 |
|
—— | tacrolimus | 104987-11-3 | C44H69NO12 |
|
—— | 8-ethyl-5-phenyl-6-7-8-9-tetrahydro-1H-pyrrolo-[3,2-h]-isoquinoline-2,3-dione-3-oxim | 309711-59-9 | C19H19N3O2 |
|